Literature DB >> 7733972

Immunohistochemical localization of guanylin in the rat small intestine and colon.

M B Cohen1, D P Witte, J A Hawkins, M G Currie.   

Abstract

Guanylin is an endogenous mammalian ligand which binds to guanylate cyclase C (GC-C), the Escherichia coli heat-stable enterotoxin receptor. This interaction results in intestinal Cl- and fluid secretion, which is largely, if not exclusively, mediated through the cystic fibrosis transmembrane regulator (CFTR). Using in situ hybridization, we have previously localized guanylin mRNA to villus epithelial cells of the rat small intestine and to superficial epithelial cells of the rat colon. In the present study, we demonstrate immunoreactive guanylin in a subpopulation of goblet cells in the rat jejunum and ileum. In the colon, there was immunostaining of superficial epithelial cells and goblet cells. The immunohistochemical localization of guanylin parallels the observed distribution of guanylin mRNA. Localization of guanylin in goblet cells leads us to speculate that an in vivo function of guanylin regulated, CFTR-mediated Cl- secretion is to hydrate intestinal mucin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733972     DOI: 10.1006/bbrc.1995.1571

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation.

Authors:  Kris A Steinbrecher; Steve A Wowk; Jeffrey A Rudolph; David P Witte; Mitchell B Cohen
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Enteroendocrine and neuronal mechanisms in pathophysiology of acute infectious diarrhea.

Authors:  Michael Camilleri; Sara Nullens; Tyler Nelsen
Journal:  Dig Dis Sci       Date:  2011-10-15       Impact factor: 3.199

3.  RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study.

Authors:  Michael Camilleri; Paula Carlson; Andres Acosta; Irene Busciglio; Asha A Nair; Simon J Gibbons; Gianrico Farrugia; Eric W Klee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-24       Impact factor: 4.052

4.  Natriuretic and antikaliuretic effects of uroguanylin and prouroguanylin in the rat.

Authors:  Nicholas G Moss; Dorothy A Riguera; Robert C Fellner; Christopher Cazzolla; Michael F Goy
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-22

Review 5.  Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.

Authors:  Allison A Aka; Jeff A Rappaport; Amanda M Pattison; Takami Sato; Adam E Snook; Scott A Waldman
Journal:  Expert Rev Clin Pharmacol       Date:  2017-04-10       Impact factor: 5.045

Review 6.  Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C.

Authors:  Arie B Vaandrager
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

7.  Enterotoxin preconditioning restores calcium-sensing receptor-mediated cytostasis in colon cancer cells.

Authors:  Giovanni M Pitari; Jieru E Lin; Fawad J Shah; Wilhelm J Lubbe; David S Zuzga; Peng Li; Stephanie Schulz; Scott A Waldman
Journal:  Carcinogenesis       Date:  2008-06-19       Impact factor: 4.944

Review 8.  Pendrin, a novel transcriptional target of the uroguanylin system.

Authors:  Julia Rozenfeld; Osnat Tal; Orly Kladnitsky; Lior Adler; Edna Efrati; Stephen L Carrithers; Seth L Alper; Israel Zelikovic
Journal:  Cell Physiol Biochem       Date:  2013-12-18

9.  The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling.

Authors:  Jieru Egeria Lin; Peng Li; Adam Eugene Snook; Stephanie Schulz; Abhijit Dasgupta; Terry Marie Hyslop; Ahmara Vivian Gibbons; Glen Marszlowicz; Giovanni Mario Pitari; Scott Arthur Waldman
Journal:  Gastroenterology       Date:  2009-09-06       Impact factor: 22.682

10.  Guanylate cyclase C signaling: an intestinal secretory pathway where bugs, genes and new drugs intersect.

Authors:  Michael Camilleri
Journal:  Genome Med       Date:  2012-06-26       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.